{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360004232456804480.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.preteyeres.2017.10.005"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1350946217300599?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S1350946217300599?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"29111299"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia"}],"description":[{"notation":[{"@value":"Pathologic myopia is a leading cause of visual impairment. Development of myopic choroidal neovascularization (CNV) is one of the most common complications that leads to central vision loss in patients with pathologic myopia. If left untreated, it can cause scarring with expanding macular atrophy leading to irreversible visual loss in a period as short as 5 years. Advancements in multimodal imaging technology have furthered our understanding of the condition; however, further studies are necessary to extend its utility in the diagnosis of myopic CNV. Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy has become the standard-of-care and the recommended first-line treatment option for myopic CNV. Long-term studies have demonstrated that early treatment of confirmed myopic CNV cases with an intravitreal anti-VEGF agent is useful to avoid late-stage complications. This strategy has also been shown to achieve visual outcome improvements for up to 4 years and visual stabilization up to 6 years. This review article provides an overview of the current knowledge on myopic CNV and discusses recent updates in the diagnosis and management of the condition. Furthermore, treatment recommendations are provided based on the authors' expert opinions."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380004232456804482","@type":"Researcher","foaf:name":[{"@value":"Kyoko Ohno-Matsui"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232456804480","@type":"Researcher","foaf:name":[{"@value":"Yasushi Ikuno"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232456804481","@type":"Researcher","foaf:name":[{"@value":"Timothy Y.Y. Lai"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232456804483","@type":"Researcher","foaf:name":[{"@value":"Chui Ming Gemmy Cheung"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"13509462"}],"prism:publicationName":[{"@value":"Progress in Retinal and Eye Research"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2018-03","prism:volume":"63","prism:startingPage":"92","prism:endingPage":"106"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S1350946217300599?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S1350946217300599?httpAccept=text/plain"}],"createdAt":"2017-10-28","modifiedAt":"2025-10-22","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Vascular%20Endothelial%20Growth%20Factor%20A","dc:title":"Vascular Endothelial Growth Factor A"},{"@id":"https://cir.nii.ac.jp/all?q=Angiogenesis%20Inhibitors","dc:title":"Angiogenesis Inhibitors"},{"@id":"https://cir.nii.ac.jp/all?q=Diagnostic%20Techniques,%20Ophthalmological","dc:title":"Diagnostic Techniques, Ophthalmological"},{"@id":"https://cir.nii.ac.jp/all?q=Choroidal%20Neovascularization","dc:title":"Choroidal Neovascularization"},{"@id":"https://cir.nii.ac.jp/all?q=Intravitreal%20Injections","dc:title":"Intravitreal Injections"},{"@id":"https://cir.nii.ac.jp/all?q=Myopia,%20Degenerative","dc:title":"Myopia, Degenerative"},{"@id":"https://cir.nii.ac.jp/all?q=Practice%20Guidelines%20as%20Topic","dc:title":"Practice Guidelines as Topic"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040282256809047680","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"15H04993"},{"@type":"JGN","@value":"JP15H04993"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15H04993/"}],"notation":[{"@language":"ja","@value":"病的近視による眼球変形機序の四次元時空的解明と分子標的治療の確立"},{"@language":"en","@value":"Pathogenesis and new treatment for eye deformity due to pathologic myopia"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050001335759240448","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization."}]},{"@id":"https://cir.nii.ac.jp/crid/1050285299733132416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Usefulness of Denoising Process to Depict Myopic Choroidal Neovascularisation Using a Single Optical Coherence Tomography Angiography Image"}]},{"@id":"https://cir.nii.ac.jp/crid/1050297969507632896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Ten-year visual outcome and change in chorioretinal atrophy after intravitreal ranibizumab for macular neovascularization in pathologic myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360001114218137088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Novel perspectives on swept-source optical coherence tomography"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002215787661184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"International Photographic Classification and Grading System for Myopic Maculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002216104212224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"RADIANCE: A Randomized Controlled Study of Ranibizumab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232411844608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Comparison of Clinical Features in Highly Myopic Eyes with and without a Dome-Shaped Macula"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004234891293312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"FIVE-YEAR OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236046075136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Possible connection of short posterior ciliary arteries to <i>choroidal neovascularisations in eyes with pathologic myopia</i>"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236343494912","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Aqueous Concentrations of Vascular Endothelial Growth Factor in Eyes with High Myopia with and without Choroidal Neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142906833280","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hyperreflective Material in Optical Coherence Tomography Images of Eyes with Myopic Choroidal Neovascularization May Affect the Visual Outcome"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144063211392","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Swept-source optical coherence tomography angiography for choroidal neovascularization after bevacizumab and photodynamic therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144329926528","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long-Term Follow-Up of Myopic Choroidal Neovascularization Treated with Ranibizumab"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144345523968","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144584928256","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145184461824","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Dome-Shaped Macular Configuration: Longitudinal Changes in the Sclera and Choroid by Swept-Source Optical Coherence Tomography Over Two Years"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145504384896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Myopic choroidal neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145587029760","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Myopic choroidal neovascularization: natural course and treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146605797632","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Choroidal Thickness after Treatment for Myopic Choroidal Neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017279863710080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Characteristics of choroidal neovascularization in elderly eyes with high myopia not meeting the pathologic myopia definition"}]},{"@id":"https://cir.nii.ac.jp/crid/1360282589181618944","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Updates of pathologic myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283690764350464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Morphologic Characteristics of Macular Complications of a Dome-Shaped Macula Determined by Swept-Source Optical Coherence Tomography"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283691080958720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285707388416896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Acquired Optic Nerve and Peripapillary Pits in Pathologic Myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285712555199872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Glaucomatous-Type Optic Discs in High Myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360286990825540224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619847294720","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Characteristics of Periconus Choroidal Neovascularization in Pathologic Myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292620640478976","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Optical Coherence Tomography Angiography of Choroidal Neovascularization Secondary to Pathologic Myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302864783594240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Characteristics and Prevalence of Staphyloma Edges at Different Ages in Highly Myopic Eyes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302866844938368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Three cases of macular retinal detachment exacerbated during follow-up with myopic foveoschisis around myopic choroidal neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306904417057408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"OUTCOMES OF PRO RE NATA VERSUS TREAT-AND-EXTEND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS FOR MYOPIC MACULAR NEOVASCULARIZATION IN MULTIETHNIC PATIENTS IN THE UNITED STATES"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905152496384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Genome-wide Meta-analysis for Myopic Macular Neovascularization Identified a Novel Susceptibility Locus and Revealed a Shared Genetic Susceptibility with Age-Related Macular Degeneration"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306905167642752","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Systemic Oxidative Stress Level as a Pathological and Prognostic Factor in Myopic Choroidal Neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565166057622912","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Vascular Endothelial Growth Factor Gene and the Response to Anti-Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in High Myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565166057645440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Proposed Classification of Posterior Staphylomas Based on Analyses of Eye Shape by Three-Dimensional Magnetic Resonance Imaging and Wide-Field Fundus Imaging"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181902886784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Two-Year Visual Results for Older Asian Women Treated With Photodynamic Therapy or Bevacizumab for Myopic Choroidal Neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567186498815616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Macular Microstructures and Prognostic Factors in Myopic Subretinal Hemorrhages"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092787277952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095092909952","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"INTRAVITREAL RANIBIZUMAB VERSUS BEVACIZUMAB FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095137323008","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Optical coherence tomography angiography in retinal diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574096152025088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ranibizumab for Neovascular Age-Related Macular Degeneration"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232387445120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"IMI Pathologic Myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569330329600","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Epidemiology and Disease Burden of Pathologic Myopia and Myopic Choroidal Neovascularization: An Evidence-Based Systematic Review"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593783748608","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"PREVALENCE AND CHARACTERISTICS OF MULTIFOCAL CHOROIDITIS/PUNCTATE INNER CHOROIDOPATHY IN PATHOLOGIC MYOPIA EYES WITH PATCHY ATROPHY"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593811591808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Flow pattern and perforating vessels in three different phases of myopic choroidal neovascularization seen by swept-source optical coherence tomography angiography"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865816792449536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"MORPHOLOGIC CHARACTERISTICS AND PROGRESSION PATTERNS OF MACULAR NEOVASCULARIZATION–RELATED ATROPHY IN EYES WITH PATHOLOGIC MYOPIA"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044092960896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The analysis of lacquer crack in the assessment of myopic choroidal neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045108761600","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045736398720","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045982660224","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"CORRELATION BETWEEN VISUAL PROGNOSIS AND FUNDUS AUTOFLUORESCENCE AND OPTICAL COHERENCE TOMOGRAPHIC FINDINGS IN HIGHLY MYOPIC EYES WITH SUBMACULAR HEMORRHAGE AND WITHOUT CHOROIDAL NEOVASCULARIZATION"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137046150501248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Optical Coherence Tomography Angiography Of Pathological Myopia Sourced and Idiopathic Choroidal Neovascularization With Follow-Up"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418518965341312","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Etiology of Choroidal Neovascularization in Young Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519337185536","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"CORRESPONDENCE OF LEAKAGE ON FLUORESCEIN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS IN DIAGNOSIS AND MONITORING OF MYOPIC CHOROIDAL NEOVASCULARIZATION TREATED WITH BEVACIZUMAB"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519691692800","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519974024832","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ocular Risk Factors for Choroidal Neovascularization in Pathologic Myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520075175680","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"CHARACTERISTIC SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY FINDINGS OF MULTIFOCAL CHOROIDITIS"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520705286528","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Photodynamic Therapy with Verteporfin for Choroidal Neovascularization of Pathologic Myopia in Japanese Patients: Comparison with Nontreated Controls"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995719782528","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"MYOPIC CHOROIDAL NEOVASCULARIZATION"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699996309606272","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long-term Pattern of Progression of Myopic Maculopathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699996468516352","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"REDEFINING MULTIFOCAL CHOROIDITIS AND PANUVEITIS AND PUNCTATE INNER CHOROIDOPATHY THROUGH MULTIMODAL IMAGING"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468737562496","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468812611584","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469966249344","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Anti-VEGF Therapy in Myopic Choroidal Neovascularization: Long-Term Results"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470974800768","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"CEREBROVASCULAR ACCIDENTS IN PATIENTS TREATED FOR CHOROIDAL NEOVASCULARIZATION WITH RANIBIZUMAB IN RANDOMIZED CONTROLLED TRIALS"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262944992927360","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Polypoidal Choroidal Vasculopathy in Tilted Disk Syndrome and High Myopia With Staphyloma"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418372647168","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Choroidal Neovascularization Analyzed on Ultrahigh-Speed Swept-Source Optical Coherence Tomography Angiography Compared to Spectral-Domain Optical Coherence Tomography Angiography"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418733976448","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Spectral-Domain Optical Coherence Tomography of Subretinal Hyperreflective Exudation in Myopic Choroidal Neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418855135104","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"MACULAR COMPLICATIONS ON THE BORDER OF AN INFERIOR STAPHYLOMA ASSOCIATED WITH TILTED DISC SYNDROME"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544418960430720","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419935318912","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Association between Choroidal Morphology and Anti-Vascular Endothelial Growth Factor Treatment Outcome in Myopic Choroidal Neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420633940736","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Epidemiology and Diagnosis of Myopic Choroidal Neovascularization in Asia"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544421295375104","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"FACTORS INFLUENCING NEED FOR RETREATMENT AND LONG-TERM VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893482762368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Peripapillary Changes Detected by Optical Coherence Tomography in Eyes with High Myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893935077760","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894126214400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-year outcome"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370599311360","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388843371787904","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long-term results of intravitreal bevacizumab for choroidal neovascularisation in pathological myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388843437035392","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Current and emerging treatment options for myopic choroidal neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388843863629312","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intravitreal bevacizumab as a treatment for choroidal neovascularisation secondary to myopia: 4-year study results"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844362886656","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388846197174912","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Aqueous Humor Levels of Vascular Endothelial Growth Factor and Pigment Epithelium–Derived Factor in Polypoidal Choroidal Vasculopathy and Choroidal Neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318302438784","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318402177280","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Complications associated with posterior staphyloma"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318785903744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Myopic choroidal neovascularisation: current concepts and update on clinical management"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318887710848","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularisation"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319102084352","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Refractive Error and Risk of Early or Late Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319212815744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320613797632","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670321305789952","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The application of optical coherence tomography angiography in uveitis and inflammatory eye diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794339772672","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Prognostic Factors of Eyes With Naïve Subfoveal Myopic Choroidal Neovascularization After Intravitreal Bevacizumab"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951794604229760","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Natural History of Choroidal Neovascularization in Degenerative Myopia"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951796289178496","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Neovascular Age-related Macular Degeneration: Intraocular Cytokines and Growth Factors and the Influence of Therapy with Ranibizumab"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269513345920","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: Same or different disease?"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269910470784","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Angiographic and Optical Coherence Tomography Characteristics of Recent Myopic Choroidal Neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270394341760","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ranibizumab in Myopic Choroidal Neovascularization: A Subgroup Analysis by Ethnicity, Age, and Ocular Characteristics in RADIANCE"}]},{"@id":"https://cir.nii.ac.jp/crid/1371131417139458049","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Long-term outcomes of ranibizumab treatment of myopic choroidal neovascularization in east-Asian patients from the RADIANCE study"}]},{"@id":"https://cir.nii.ac.jp/crid/1371131417139458313","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Efficacy and safety of ranibizumab versus verteporfin photodynamic therapy in Asian patients with myopic choroidal neovascularization: 12-month results from BRILLIANCE"}]},{"@id":"https://cir.nii.ac.jp/crid/1371131417139458574","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Features of optical coherence tomography predictive of choroidal neovascularisation treatment response in pathological myopia in association with fluorescein angiography"}]},{"@id":"https://cir.nii.ac.jp/crid/1521699229649219200","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clinical investigation: Macular detachment after successful intravitreal bevacizumab for myopic choroidal neovascularization"},{"@language":"ja-Kana","@value":"Clinical investigation Macular detachment after successful intravitreal bevacizumab for myopic choroidal neovascularization"}]},{"@id":"https://cir.nii.ac.jp/crid/1524232505436441472","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A case of chronic central serous chorioretinopathy on the border of a posterior staphyloma in an eye with pathologic myopia"},{"@language":"ja-Kana","@value":"A case of chronic central serous chorioretinopathy on the border of a posterior staphyloma in an eye with pathologic myopia"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.preteyeres.2017.10.005"},{"@type":"KAKEN","@value":"PRODUCT-21724565"},{"@type":"OPENAIRE","@value":"doi_dedup___::7bdb4fc25070274b81070aae6df4014d"},{"@type":"CROSSREF","@value":"10.1136/bjophthalmol-2018-312015_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.3390/jcm9082394_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1097/iae.0000000000003383_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1038/s41598-022-18074-2_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1007/s00417-018-04214-w_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1167/iovs.65.1.32_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1016/j.ajoc.2023.101899_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1097/iae.0000000000004256_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1016/j.oret.2024.09.016_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1016/j.xops.2024.100550_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0227557_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1167/iovs.62.5.5_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1007/s00417-021-05134-y_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1097/iae.0000000000003869_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1097/iae.0000000000003863_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"},{"@type":"CROSSREF","@value":"10.1038/s41598-020-62607-6_references_DOI_C0AopqJaQUUXrSQcbvWeprsXYXK"}]}